Methods to improve medication compliance and psychological support for Finerenone patients

Finerenone is a new type of non-steroidal selective mineral receptor antagonist, mainly used in patients with chronic kidney disease (CKD) combined with type 2 diabetes to slow down the deterioration of renal function and reduce the risk of cardiovascular events. Since this type of disease often requires long-term and continuous medication management, patient medication compliance becomes a key factor in the success or failure of treatment. Improving the medication compliance of fenelidone and providing psychological support are of great significance to ensure the treatment effect and patients' quality of life.

First, enhancing patients' awareness of the efficacy and importance of fenelidone is the basis for improving compliance. Medical staff should introduce to patients in detail the role of fenelidone in delaying the progression of kidney disease and preventing cardiovascular risks, as well as the positive impact of persisting in taking the medication on prolonging life and improving quality of life, in plain language. Improving patients' self-management awareness and sense of responsibility through education can help reduce missed doses and incorrect doses.

Secondly, it is equally important to establish a scientific medication plan and reminder mechanism. Patients can ensure on-time medication by formulating a fixed daily medication schedule, using mobile phone alarm clocks, medication reminder apps, or family members to assist and supervise. In addition, regular follow-up and re-examination can help the medical team understand the patient's medication status in a timely manner, answer questions, adjust the treatment plan, and further promote patient adherence to treatment.

In terms of psychological support, patients with chronic diseases often face negative emotions such as anxiety and depression caused by long-term treatment, which may affect their enthusiasm for taking medication. Carrying out psychological counseling, providing psychological consultation and encouraging patients to participate in patient mutual aid groups can effectively relieve psychological pressure and enhance treatment confidence. At the same time, patient listening and positive encouragement from medical staff have a positive effect on improving patient compliance.

In short, improving the medication compliance of fenelidone patients requires coordinated efforts from many aspects, including knowledge popularization, medication management and psychological support, to build a comprehensive support system. Only with the active cooperation of patients and the continued attention of the medical team can the maximum clinical benefit of fenelidone treatment be achieved and the effective control of patients' renal health and cardiovascular risk be promoted.

Reference materials:https://www.drugs.com/